Session Details
[GS04]The development of pharmaceutical research and contribution to medical care opened up by the next-generation young researchers
Mon. Mar 29, 2021 1:15 PM - 3:15 PM JST
Mon. Mar 29, 2021 4:15 AM - 6:15 AM UTC
Mon. Mar 29, 2021 4:15 AM - 6:15 AM UTC
[Room D] Oral Presentation D Online
Organizer: Uchida Mami (Dep. Clin. Pharm., Grad. Sch. Pharm. Sci., Matsuyama Univ.), Tachibana Dan (Sch. Pharm. Sci., Kobe Gakuin Univ.)
The ratio of the elderly population aged 65 and over to the total population in Japan (2020) is the highest (28.9%) in the world, and it is expected to continue to rise in the future. In a super-aging society, the number of patients with cancer, cardiovascular disease, dementia and depressive illness is increasing, and it is necessary to clarify the causes of onset and/or progression and problems with drug treatment.
Therefore, this symposium will consist of research presentations from next-generation young researchers working on a basic research focused on elucidation of pathological conditions of dementia, depressive illness and pain and establishment of new drug treatments for such illnesses, and clinical research verifying new effects of existing drugs (prevention and treatment of side effects induced by various anticancer drugs) from the view of drug repositioning. We really hope that this symposium will provide a great opportunity to exchange opinions and to share the latest information on various problems in clinical practice and their solutions for students and young researchers who will be responsible for future medical care.
Therefore, this symposium will consist of research presentations from next-generation young researchers working on a basic research focused on elucidation of pathological conditions of dementia, depressive illness and pain and establishment of new drug treatments for such illnesses, and clinical research verifying new effects of existing drugs (prevention and treatment of side effects induced by various anticancer drugs) from the view of drug repositioning. We really hope that this symposium will provide a great opportunity to exchange opinions and to share the latest information on various problems in clinical practice and their solutions for students and young researchers who will be responsible for future medical care.
オーガナイザー挨拶：橘 男（神戸学院大薬）
[GS04-1]PACAP in the paraventricular nucleus of the hypothalamus contributes to the development of anxiety-like behavior associated with peripheral neuropathic pain.
○Kohei Hashiguchi1, Yuki Kambe1, Mitsutaka Sugimura1, Takashi Kurihara1, Atsuro Miyata1 (1. Grad. Sch. Med. Dent. Sci., Kagoshima Univ.)
[GS04-2]Changes of fatty acid-related factors in the brain of pain model mice
○Dan Tachibana1, Kazuo Nakamoto1, Shogo Tokuyama1 (1. Sch. Pharm. Sci., Kobe Gakuin Univ.)
[GS04-3]Effect of Lactobacillus gasseri OLL2809 on mouse depressive-like behavior.
○Chihiro Okujima1, Ami Otsuka1, Shinki Ishii2, Naoya Hashikawa1, Narumi Hashikawa1 (1. Grad. of Life Sci., Okayama Univ. of Sci., 2. Dept. of Life Sci., Okayama Univ. of Sci.)
[GS04-4]Improvement effect of sak3, t-type calcium channel activator, on a mouse model of dementia with lewy bodies.
○Tomohide Degawa1, Jing Xu1, Ichiro Kawahata1, Kohji Fukunaga1 (1. Grad. Sch. Parmaceu. Sci. Tohoku. Univ.)
[GS04-5]Renin-angiotensin-aldosterone system inhibitors suppress the onset of oxaliplatin-induced peripheral neuropathy
○Mami Uchida1, Soichiro Ushio2, Takahiro Nimura3, Noriaki Hidaka4, Akihiro Tanaka4, Yoshihisa Kitamura5, Toshiaki Sendo2, Yoshito Zamami3, Keisuke Ishizawa3, Kenshi Takechi1,6, Kazuhiko Shibata6, Hiroyuki Namba6, Hiromu Kawasaki1, Shingo Takatori1,6 (1. Dep. Clin. Pharm., Grad. Sch. Pharm. Sci., Matsuyama Univ., 2. Dept. Pharm., Okayama Univ. Hosp., 3. Dep. Clin. Pharmcol. Ther., Grad. Sch. Bio. Sci., Tokushima Univ., 4. Dept. Pharm., Ehime Univ. Hosp., 5. Dep. Pharmacother. Sch. Pharm. Sci., Shujitsu Univ., 6. Dep. Clin. Pharm., Colleg. Pharm. Sci., Matsuyama Univ.)
[GS04-6]Exploration of preventive drugs for doxorubicin-induced myocarditis Cardiomyopathy utilizing large-scale medical database
Yoshika Sakamoto1, Yoshito Zamami2,3, ○Takahiro Niimura2, Fuka Aizawa3, Kenta Yagi4, Mitsuhiro Goda4, Yuki Izawa-Ishizawa5, Keisuke Ishizawa2,3 (1. Fac. of Pharm. Sci., Tokushima Univ., 2. Grad. Sch. of Bio. Sci., Tokushima Univ., 3. Dept. of Pharmacy, Tokushima Univ. Hosp., 4. Clin. Res. Ctr. Dev. Ther., Tokushima Univ. Hosp., 5. AWA Support Center, Tokushima Univ.)